Significant weight loss associated with GLP-1 medications is being linked to a growing range of cosmetic concerns, with plastic surgeons reporting increased demand for corrective procedures targeting changes in the face and body. Reports from U.S. specialists indicate patients are seeking treatment for sagging skin, reduced facial volume, and altered body contours following use of drugs such as semaglutide.
Facial plastic surgeon Sachin S. Parikh noted that fat reduction from semaglutide use can affect small fat pads across the body, including the ears, leading to visible changes sometimes referred to in clinical discussions as "Ozempic earlobes." The observations were shared in comments published through Fox News, which reported that patients describe ears appearing thinner or more elongated following weight loss.
